Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Magnetic Resonance in Chemistry : MRC|March 17, 2009
Chiral NMR discrimination of the diastereoisomeric salts of the H3-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazoleMirko Rivara, Valentina Zuliani, Marco Fantini, et al.
The Journal of Organic Chemistry|May 10, 2007
A practical synthesis of 2,4(5)-diarylimidazoles from simple building blocksValentina Zuliani, Giuseppe Cocconcelli, Marco Fantini, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
pH-partition profiles of 4-(3-oxo-1,2-benzisothiazolin-2-yl)phenyl and phenoxyalkanoic acidsClaudia Silva, Marco Mor, Federica Vacondio, et al.
European Journal of Medicinal Chemistry|June 15, 2015
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational designMarco Pieroni, Baojie Wan, Valentina Zuliani, et al.
Bioorganic & Medicinal Chemistry|October 15, 2010
Anticonvulsant activity of 2,4(1H)-diarylimidazoles in mice and rats acute seizure modelsValentina Zuliani, Marco Fantini, Aradhya Nigam, et al.
Bioorganic & Medicinal Chemistry|January 16, 2020
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell lineAlessio Malacrida, Mirko Rivara, Alessandro Di Domizio, et al.
Bioorganic & Medicinal Chemistry|November 24, 2004
Fluorescent ligands for the histamine H2 receptor: synthesis and preliminary characterizationSarel F Malan, Andre van Marle, Wiro M Menge, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2006
5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activityCaterina Carmi, Andrea Cavazzoni, Valentina Zuliani, et al.
Biology|January 21, 2022
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell LinesAlessio Malacrida, Alessandro Di Domizio, Angela Bentivegna, et al.
Drug Design and Discovery|December 17, 2003
Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar groupSilvia Rivara, Marco Mor, Fabrizio Bordi, et al.
Pageof 3